Antiviral Drug Development against RNA Viruses: Progress, Clinical Translation and Persistent Challenges
Antiviral drug development has produced transformative treatments for some RNA-virus infections while leaving major gaps in acute respiratory, haemorrhagic and enteric disease. The unevenness of progress cannot be explained by target availability alone. This critical narrative review examines how viral biology, pharmac...